Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Corcept Therapeutics

    World Rank (Aug-2026)
    1,862
    Market Cap (Aug-2026)
    12.374 Billion USD
    World Rank (Jan-05-2024)
    4,813
    Market Cap (Jan-05-2024)
    2.619 Billion USD
    World Rank (Jul-30-2023)
    4,835
    Market Cap (Jul-30-2023)
    2.575 Billion USD
    World Rank (Dec-25-2022)
    5,084
    Market Cap (Dec-25-2022)
    2.223 Billion USD
    World Rank (Jan-07-2022)
    5,900
    Market Cap (Jan-07-2022)
    2.20 Billion USD
    Annual Revenue in USD
    761 Million USD
    Annual Operating Income in USD
    45 Million USD
    Annual Net Income in USD
    100 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Corcept Therapeutics is a Pharmaceutical company. It plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric and ophthalmologic diseases. The headquarters is in USA.
    Company Website
    CORCEPT THERAPEUTICS INCORPORATED

  2. Arrowhead Pharmaceuticals

    World Rank (Aug-2026)
    1,882
    Market Cap (Aug-2026)
    12.238 Billion USD
    World Rank (Jan-05-2024)
    3,718
    Market Cap (Jan-05-2024)
    3.710 Billion USD
    World Rank (Jul-30-2023)
    3,705
    Market Cap (Jul-30-2023)
    3.755 Billion USD
    World Rank (Dec-25-2022)
    3,059
    Market Cap (Dec-25-2022)
    4.359 Billion USD
    World Rank (Jan-07-2022)
    2,778
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    829 Million USD
    Annual Operating Income in USD
    98 Million USD
    Annual Net Income in USD
    -2 Million USD
    Annual Results for Period Ending
    For year ending September-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

    Company Website
    ARROWHEAD PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  3. Elanco Animal Health

    World Rank (Aug-2026)
    1,934
    Market Cap (Aug-2026)
    11.826 Billion USD
    World Rank (Jan-05-2024)
    2,196
    Market Cap (Jan-05-2024)
    7.170 Billion USD
    World Rank (Jul-30-2023)
    2,569
    Market Cap (Jul-30-2023)
    5.906 Billion USD
    World Rank (Dec-25-2022)
    2,489
    Market Cap (Dec-25-2022)
    5.553 Billion USD
    World Rank (Jan-07-2022)
    1,541
    Market Cap (Jan-07-2022)
    12.80 Billion USD
    Annual Revenue in USD
    4,715 Million USD
    Annual Net Income in USD
    -232 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    ELANCO ANIMAL HEALTH is a pharmaceutical company related to animal health care. It develops, manufactures, and markets products for companion and food for animals. The main product of the company is pharmaceutical drugs for animals. The headquarters is in USA.

    Company Website
    ELANCO ANIMAL HEALTH
    Wikipedia
    Wikipedia

  4. Madrigal Pharmaceuticals

    World Rank (Aug-2026)
    1,943
    Market Cap (Aug-2026)
    11.727 Billion USD
    World Rank (Jan-05-2024)
    3,310
    Market Cap (Jan-05-2024)
    4.308 Billion USD
    World Rank (Jul-30-2023)
    3,701
    Market Cap (Jul-30-2023)
    3.759 Billion USD
    World Rank (Dec-25-2022)
    2,892
    Market Cap (Dec-25-2022)
    4.679 Billion USD
    World Rank (Jan-07-2022)
    8,034
    Market Cap (Jan-07-2022)
    1.32 Billion USD
    Annual Revenue in USD
    958 Million USD
    Annual Operating Income in USD
    -300 Million USD
    Annual Net Income in USD
    -288 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Madrigal Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver which is a key regulatory mechanism common to a spectrum of cardio metabolic and fatty liver diseases with high unmet medical need. The headquarters is in USA.

    Company Website
    MADRIGAL PHARMACEUTICALS INC

  5. Axsome Therapeutics

    World Rank (Aug-2026)
    2,018
    Market Cap (Aug-2026)
    11.192 Billion USD
    World Rank (Jan-05-2024)
    3,584
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    3,778
    Market Cap (Jul-30-2023)
    3.664 Billion USD
    World Rank (Dec-25-2022)
    3,898
    Market Cap (Dec-25-2022)
    3.204 Billion USD
    World Rank (Jan-07-2022)
    8,340
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    638 Million USD
    Annual Operating Income in USD
    -167 Million USD
    Annual Net Income in USD
    -183 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Axsome Therapeutics is a biopharmaceutical company. The headquarters is in USA.

    Company Website
    AXSOME THERAPEUTICS

  6. Summit Therapeutics

    World Rank (Aug-2026)
    2,098
    Market Cap (Aug-2026)
    10.650 Billion USD
    World Rank (Jan-05-2024)
    5,892
    Market Cap (Jan-05-2024)
    1.889 Billion USD
    World Rank (Jul-30-2023)
    6,946
    Market Cap (Jul-30-2023)
    1.479 Billion USD
    World Rank (Dec-25-2022)
    15,677
    Market Cap (Dec-25-2022)
    0.302 Billion USD
    World Rank (Jan-07-2022)
    17,453
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Net Income in USD
    -1,080 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SUMMIT THERAPEUTICS

  7. Cytokinetics

    World Rank (Aug-2026)
    2,164
    Market Cap (Aug-2026)
    10.306 Billion USD
    World Rank (Jan-05-2024)
    1,870
    Market Cap (Jan-05-2024)
    8.652 Billion USD
    World Rank (Jul-30-2023)
    4,175
    Market Cap (Jul-30-2023)
    3.180 Billion USD
    World Rank (Dec-25-2022)
    3,096
    Market Cap (Dec-25-2022)
    4.314 Billion USD
    World Rank (Jan-07-2022)
    4,885
    Market Cap (Jan-07-2022)
    2.97 Billion USD
    Annual Revenue in USD
    88 Million USD
    Annual Operating Income in USD
    -612 Million USD
    Annual Net Income in USD
    -785 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Cytokinetics is the Leading Muscle Biology Biopharmaceutical company. The headquarters is in USA.

    Facts About Company

    Cytokinetics Annual Total Revenue for year ending Dec-2022 was 94 million USD and and Net loss for year ending Dec-2022 was -388 million USD.

    Cytokinetics Annual Total Revenue for year ending Dec-2021 was 70 million USD and and Net loss for year ending Dec-2021 was -215 million USD.

    As on 2022, Cytokinetics has 409 employees.

    Company Website
    CYTOKINETICS
    Wikipedia
    Wikipedia

  8. Praxis Precision Medicines Inc.

    World Rank (Aug-2026)
    2,178
    Market Cap (Aug-2026)
    10.241 Billion USD
    World Rank (Jan-05-2024)
    17,121
    Market Cap (Jan-05-2024)
    0.232 Billion USD
    World Rank (Jul-30-2023)
    20,456
    Market Cap (Jul-30-2023)
    0.126 Billion USD
    World Rank (Dec-25-2022)
    20,944
    Market Cap (Dec-25-2022)
    0.114 Billion USD
    World Rank (Jan-07-2022)
    10,597
    Market Cap (Jan-07-2022)
    0.81 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -326 Million USD
    Annual Net Income in USD
    -303 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Praxis is a Clinical Stage Biopharmaceutical company translating genetic insights into the development of therapies for patients affected by central nervous system (“CNS”) disorders characterized by neuronal imbalance. The company annual net income is 35.5 million USD. The headquarters is in USA.
    Company Website
    PRAXIS PRECISION MEDICINES, INC.

  9. Protagonist Therapeutics

    World Rank (Aug-2026)
    2,204
    Market Cap (Aug-2026)
    10.036 Billion USD
    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    46 Million USD
    Annual Operating Income in USD
    -158 Million USD
    Annual Net Income in USD
    -130 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Stuttgart
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

    Company Website
    PROTAGONIST THERAPEUTICS

  10. Nuvalent Inc.

    World Rank (Aug-2026)
    2,239
    Market Cap (Aug-2026)
    9.830 Billion USD
    World Rank (Jan-05-2024)
    3,133
    Market Cap (Jan-05-2024)
    4.610 Billion USD
    World Rank (Jul-30-2023)
    4,632
    Market Cap (Jul-30-2023)
    2.756 Billion USD
    World Rank (Dec-25-2022)
    6,273
    Market Cap (Dec-25-2022)
    1.605 Billion USD
    World Rank (Jan-07-2022)
    11,341
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Annual Operating Income in USD
    -414 Million USD
    Annual Net Income in USD
    -425 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Nuvalent, Inc., is a clinical stage biopharmaceutical company, and it develops therapies for patients with cancer.

    The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts, USA.

    Company Website
    NUVALENT, INC.

Share